A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) (PROTECT-3)

Trial Details

  • 510 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Drug: LT-02 Drug: LT-02 Placebo
  • Clinic: GI Research Institute Suite 770-1190 Hornby Street

Summary

The purpose of this study is to determine whether Phosphatidylcholine (LT-02) add on treatment is effective and safe for the induction of remission in ulcerative colitis patients refractory to standard treatment with mesalamine.

Full Trial Details